Comparative Effects of Post-exercise Ingestion of a High or Low Molecular

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor)

See also
Status	Clinical Trial	Phase
Completed	`NCT05316844` - Investigation of Predictors of Typing Performance in Office Employees With Neck Pain
Not yet recruiting	`NCT06362785` - Musculoskeletal Pain, Motor Control, Risk of Falls and Virtual Reality	N/A
Completed	`NCT03685266` - Efficiency of Task Switching and Multi-tasking
Completed	`NCT03049098` - Visual Perception Exploration Using Eye-tracking Technology in High-fidelity Medical Simulation	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT05316844 - Investigation of Predictors of Typing Performance in Office Employees With Neck Pain

Not yet recruiting

NCT06362785 - Musculoskeletal Pain, Motor Control, Risk of Falls and Virtual Reality

N/A

Completed

NCT03685266 - Efficiency of Task Switching and Multi-tasking

Completed

NCT03049098 - Visual Perception Exploration Using Eye-tracking Technology in High-fidelity Medical Simulation

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02778373
Study type	Interventional
Source	Texas Christian University
Contact
Status	Completed
Phase	N/A
Start date	September 2014
Completion date	June 2015

Comparative Effects of Post-exercise Ingestion of a High or Low Molecular Weight Solution on Resistance Exercise Performance

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms